Group Lead - PMO (Capital Projects) Fresher's job

"The primary responsibility of the Group Lead, Capital project management is to lead the capital project management tram and work with execution team in order to successfully deliver the projects."

Project Planning: Planning on capital projects pipeline, annual budgeting exercise for capacity enhancements and their approvals.
Budgeting and Financial Management: Track project budgets, monitor expenses, and ensure projects are completed within budget constraints.
Project Scope and Timeline: Define project scopes, and timelines, ensuring clear deliverables and milestones.
Risk Management: Identify potential risks and develop mitigation strategies to prevent project delays or cost overruns.
Vendor Management: Coordinate with vendors, suppliers, and contractors to ensure timely delivery of materials and services.
Cross-Functional Collaboration: Collaborate with different departments such as R&D, manufacturing, operations, and regulatory affairs to ensure project goals are met.
Project Documentation: Maintain accurate project documentation, including plans, progress reports, and final project reports.
Stakeholder Communication: Communicate project updates and progress to senior management, stakeholders, and relevant teams.
Continuous Improvement: Identify opportunities for process improvement and implement best practices to enhance project management efficiency.
Reporting: Provide regular reports and presentations to senior management on the status and progress of ongoing and upcoming capital projects.

Apply Link- Apply Link mentioned in below

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.[2] Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. In 2014, Dr. Reddy Laboratories was listed among 1200 of India's most trusted brands according to the Brand Trust Report 2014, a study conducted by Trust Research Advisory, a brand analytics company.[3]
By 2007, Dr. Reddy's had seven FDA plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications five of them in India and two in the UK.[4]